Table 2.

Expression of FOXP1 in gastric cancer tissues [cases (%)], ($\overline{x}\pm s$)

Groups	Cases	FOXP1 positive rate (%)		FOXP1 low expression [Cases(%)]		P1
		Before treatment	After treatment	Before treatment	After treatment
The study group	76	10.88 ± 5.89	33.05 ± 8.56	34 (44.74)	4 (5.26)	< 0.001a
The control group	76	10.92 ± 5.94	29.26 ± 7.06	32 (42.11)	16 (21.05)	0.005b
χ2/Fisher test		0.042	2.978	0.107	–
P2		0.967	0.003	0.743c	0.020d

^aMcNemar test was used to compare the differences before and after treatment in the study group

^bMcNemar test was used to compare the differences before and after treatment in the control group

^cχ2 test was used to compare the differences between the study group and the control group before treatment

^dFisher exact test was used to compare the differences between the study group and the control group after treatment

P1 is the comparison of before and after treatment data for the same group of patients; P2 showed the comparison of data between the study and control groups at the same time point